Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)
Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)
Recruiting · NCT07298564 · Registry updated 2025-12-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS) | 46,XX disorder of sex development, Adnexal Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cysts, Dyslipidemias, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hirsutism, Hyperandrogenism, Insulin Resistance, Lipid Metabolism Disorders, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, Urogenital Abnormalities, Urogenital Diseases, Virilism, adrenogenital syndrome, disorder of pilosebaceous unit, disorder of sexual differentiation, endocrine system disorder, female reproductive system disorder, glucose metabolism disease, gonadal disorder, hyperinsulinism, metabolic disease, neoplasm, ovarian cyst, ovarian disorder, polycystic ovary syndrome, skin disorder | Recruiting | Not applicable | 2025-12-23 | NCT07298564 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Behnood Abbasi | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tara Momeni | Tehran | Iran | 1 |